Showing results (221-230 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|February 16, 2017
Ester Prodrugs of IHVR-19029 with Enhanced Oral Exposure and Prevention of Gastrointestinal Glucosidase InteractionJulia Ma, Shuo Wu, Xuexiang Zhang, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNUYameng Wang, Ting Ren, Xinxin Lai, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein InhibitorsZhe Li, James Partridge, Abel Silva-Garcia, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
From Dynamic Combinatorial Chemistry to in Vivo Evaluation of Reversible and Irreversible Myeloperoxidase InhibitorsJalal Soubhye, Michel Gelbcke, Pierre Van Antwerpen, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2Sang Joon Won, Joseph D Eschweiler, Jaimeen D Majmudar, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Synthesis, Biological Evaluation, and Autophagy Mechanism of 12N-Substituted Sophoridinamines as Novel Anticancer AgentsChongwen Bi, Na Zhang, Peng Yang, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
Lead Optimization: Synthesis and Biological Evaluation of PBT-1 Derivatives as Novel Antitumor AgentsLan Xie, Masuo Goto, Xiaoyan Chen, et al.
ACS Medicinal Chemistry Letters|December 17, 2021
Discovery of Imidazole-Based Inhibitors of Plasmodium falciparum cGMP-Dependent Protein KinaseRammohan R Yadav Bheemanaboina, Mariana Laureano de Souza, Mariana Lozano Gonzalez, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against MelanomaMargarida Granada, Eduarda Mendes, Maria Jesus Perry, et al.
Pageof 438